Save the Date:
Wednesday, 30 September 2026 | 17:00 – 18:15
Language: English
We are delighted to invite you to this webinar exploring the evolving role of precision medicine in the treatment of breast cancer.
Chair
Prof. Dr. med. Jens Huober
HOCH Health Ostschweiz
Rupert Bartsch, MD
Medical University of Vienne, Austia
Prof. Dr. med. Zsuzsanna Varga
University Hospial Zurich, Switzerland
Prof. Dr. med. Christian Kurzeder
University Hospial Base, Switzerland
Programme
The program will provide insights into the growing importance of predictive factors and biomarkers for treatment decision-making, highlighting how accurate biological characterization of tumors enables a more personalized therapeutic approach. Participants will also gain an overview of the current landscape of antibody-drug conjugates (ADCs) and discuss key topics including treatment sequencing, emerging clinical evidence, and mechanisms of resistance.
To translate science into practice, the webinar will conclude with an interactive patient case discussion, offering valuable perspectives on real-world decision-making and multidisciplinary management.
CME credits
SGGG: 1 credit
Join us for an engaging and clinically relevant discussion on how smart therapies are transforming outcomes for patients with breast cancer.
Free participation is exclusively reserved for healthcare professionals and representatives of the industry sponsoring the webinar.
Register now. We look forward to your participation.
Free participation is exclusively reserved for healthcare professionals and representatives of the industry sponsoring the webinar.